valproic acid has been researched along with Acidosis, Diabetic in 7 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Excerpt | Relevance | Reference |
---|---|---|
"A nondiabetic young male patient in hypomanic phase of bipolar disorder on maintenance treatment with sodium valproate, developed transient episode of acute pancreatitis and diabetic ketoacidosis after addition of chlorpromazine and halopridol." | 7.72 | Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. ( Gupta, SB; Laghate, VD, 2004) |
"We accepted him as type 1 diabetes mellitus (DM type 1)." | 5.33 | Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium. ( Alpaslan, T; Bulent, C; Cengiz, T; Mithat, B, 2005) |
"A nondiabetic young male patient in hypomanic phase of bipolar disorder on maintenance treatment with sodium valproate, developed transient episode of acute pancreatitis and diabetic ketoacidosis after addition of chlorpromazine and halopridol." | 3.72 | Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. ( Gupta, SB; Laghate, VD, 2004) |
"We accepted him as type 1 diabetes mellitus (DM type 1)." | 1.33 | Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium. ( Alpaslan, T; Bulent, C; Cengiz, T; Mithat, B, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Morton, A | 1 |
Tavakoli, SA | 1 |
Arguisola, MS | 1 |
Laghate, VD | 1 |
Gupta, SB | 1 |
Mithat, B | 1 |
Alpaslan, T | 1 |
Bulent, C | 1 |
Cengiz, T | 1 |
Maule, S | 1 |
Giannella, R | 1 |
Lanzio, M | 1 |
Villari, V | 1 |
Nicolai, J | 1 |
Smith, SJ | 1 |
Keunen, RW | 1 |
Turnbull, DM | 1 |
Bone, AJ | 1 |
Tames, FJ | 1 |
Wilson, L | 1 |
Baird, JD | 1 |
Sherratt, HS | 1 |
7 other studies available for valproic acid and Acidosis, Diabetic
Article | Year |
---|---|
Diabetic ketoacidosis with severe hypokalaemia and valproate-associated Fanconi syndrome.
Topics: Diabetes Mellitus; Diabetic Ketoacidosis; Fanconi Syndrome; Humans; Hypokalemia; Valproic Acid | 2023 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepi | 2003 |
Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Chlorpromazine; Diabetic Ketoacidosis; Dia | 2004 |
Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ke | 2005 |
Diabetic ketoacidosis with clozapine treatment.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clozapine; Diabetic Ketoacidosis; Drug The | 1999 |
Simultaneous side effects of both clozapine and valproate.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Carnitine; Clozapine; Coma; Diabetic Ketoacidosis; Dru | 2001 |
The effect of valproate on blood metabolite concentrations in spontaneously diabetic, ketoacidotic, BB/E Wistar rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Evaluation, Preclinic | 1985 |